Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative illness, characterized by memory loss and cognitive decline, accounting for 60-80% of dementia cases. AD is characterized by senile plaques made up of amyloid β (Aβ) protein, intracellular neurofibrillary tangles caused by hyperphosphorylation of tau protein linked with microtubules, and neuronal loss. Currently, therapeutic treatments and nanotechnological developments are effective in treating the symptoms of AD, but a cure for the illness has not yet been found. Recently, the increased study of extracellular vesicles (EVs) has led to a growing awareness of their significant involvement in neurodegenerative disorders, including AD. Exosomes are small extracellular vesicles that transport various components including messenger RNAs, non-coding RNAs, proteins, lipids, DNA, and other bioactive compounds from one cell to another, facilitating information transmission and material movement. There is growing evidence indicating that exosomes have complex functions in AD. Exosomes may have a dual role in Alzheimer's disease by contributing to neuronal death and also helping to alleviate the pathological progression of the disease. Therefore, the primary aim of this review is to outline the updated understandings on exosomes biogenesis and many functions of exosomes in the generation, conveyance, distribution, and elimination of hazardous proteins related to Alzheimer's disease. This review is intended to provide novel insights for understanding the development, specific treatment, and early detection of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They seem to display a dual function in both expediting disease progression (e.g., triggering inflammation and oxidative stress) and slowing it down (Aβ and tau clearance) [111].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [111]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Three main roles have been identified for exosomes: (i) to establish communication between cells and tissues by exchange of their intrinsic content; (ii) as diagnostic biomarkers; (iii) as DDS due to their properties (high stability, minimal immunogenicity, ease in crossing biological barriers, target specific cells or tissues, etc.) [111,112].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [111]
The cited source says what the claim attributes to it.
In the citing paper
“Exosomes are extracellular vesicles with a diameter of around 30–150 nm, secreted by most cell types in the human body, and often found in physiological fluids such as blood, CSF, urine, and saliva [111,112].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [111]
The cited source says what the claim attributes to it.
In the citing paper
“It has been demonstrated that exosomes are capable of transporting both pathogenic molecules (e.g., Aβ, tau) and therapeutic compounds.”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [91]
The cited source says what the claim attributes to it.
In the citing paper
“Their role in AD is dual: although they contribute to the disease’s pathogenesis, they also assist in the clearance of toxic protein aggregates and modulate neuroinflammation [91, 92].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 1×
“38 The Biological Characteristics of Exosomes Exosomes were first reported in the early 1980s to analyse vesicles released by various cultured cells, with a size range of 40 to 1000 nm.”
BackgroundThe biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770 · cited 1×
“9 Exosomes in the central nervous system (CNS) transmit messages locally inside cells and extensively across the brain via the cerebrospinal fluid (CSF).”
BackgroundShedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186 · cited 1×
“39,40 Exosome membranes are mostly phospholipids and proteins, with flag molecules including CD9, CD63, CD81, CD82, adhesion proteins, integrins, and glycoproteins on the surface.”
BackgroundBiological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766 · cited 1×
“36 A chemical conjugation approach may be used to modify the surface of paper in order to generate an immunoaffinity system that is based on paper.”
Method2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 3×
“214 Neuron-derived exosomes influence extracellular Aβ structure, resulting in non-toxic fibrils that promote microglia absorption.”
BackgroundMethodShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Cited by
Serrano, D. R., Juste, F., Anaya, B. J., Ramirez, B. I., Sánchez-Guirales, S. A., Moyota, J. M. Q., Hernandez, E. M., Simon, J. A., Trallero, J. M., Serrano, C., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101336 · Cited by 147
“Neurogenetic Disorders: Exosome-based strategies delivering CRISPR/Cas9, mRNA, or RNAi have been tested in mouse models of Huntington’s disease and Amyotrophic Lateral Sclerosis, enabling gene modulation within the brain and prolonging survival in early studies [82].”
Kochman, U., Sitka, H., Kuźniar, J., Czaja, M., Kozubek, P., Beszłej, J. A., & Leszek, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05417-z · Cited by 60
The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease
Daksh, R., Mathew, M. S., Bosco, A. M., Sojan, C., Tom, A. A., Bojja, S. L., & Nampoothiri, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151526 · Cited by 18
Shahlaei, M., Afkhami, H., Ahmadieh-Yazdi, A., Mirmazloumi, S. H., Sahraei, S. S., Akbari, M., Yang, P., Manoochehri, H., Tanzadehpanah, H., Mahaki, H., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118548 · Cited by 22
An Update of Salivary Biomarkers for the Diagnosis of Alzheimer’s Disease
Guo, H., RuiHuan, Y., Cheng, W., Li, Q., & Du, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052059 · Cited by 17
“Exosomes are vehicles for proteins, DNA, mRNA, miRNA, and other non-coding RNAs (ncRNAs) and are involved in A β -amyloid deposits, the formation of NFTs, neuroinflammation, and neuronal dysfunction in AD [95,96].”
Nakashima, M., Suga, N., Yoshikawa, S., & Matsuda, S. (2024) · Molecules · doi:10.3390/molecules29163922 · Cited by 11
“Additionally, certain exosomes may have a key role in Alzheimer’s disease by contributing to the alleviation of the pathological progression of the disease [91].”
BackgroundEmerging Role of Mesenchymal Stromal Cell and Exosome Therapies in Treating Cognitive Impairment
Tew, V. K., Barathan, M., Nordin, F., Law, J. X., & Ng, M. H. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030284 · Cited by 9
“These vesicles contain a variety of bioactive molecules, including proteins, lipids, and RNA, which can exert neuroprotective effects and facilitate the clearance of amyloid-beta plaques in AD models [164].”
Asgari, Z., Iranzadeh, S., & Roghani, M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111382 · Cited by 14
Targeting tau in Alzheimer’s Disease: rationale, approach and challenges
Aslanyan, A., Foiani, M. S., Giovannucci, T. A., McDade, E., Duff, K., Mummery, C. J., Schöll, M., Wildsmith, K. R., & Paterson, R. W. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00925-5 · Cited by 10
“However, the release of tau-containing EV can expedite the disease process by facilitating the dissemination of pathological proteins, triggering inflammatory response, angiogenesis and cell death [129].”
Non-Drug and Non-Invasive Therapeutic Options in Alzheimer’s Disease
Şovrea, A. S., Boşca, A. B., Dronca, E., Constantin, A.-M., Crintea, A., Suflețel, R. T., Lupean, R.-A., Ștefan, P.-A., Onofrei, M. M., Tschall, C., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13010084 · Cited by 10
“…reflected in donor differences (impacting the ADSC profiles that are extremely heterogeneous), reagent properties , called long-term safety of ADSCs in human trials [172]. in reducing models , including VEGF and BDNF, resulting in significant improvements in cognitive and memory functions [69,173].”
Ebadpour, N., Abavisani, M., Karav, S., Kesharwani, P., & Sahebkar, A. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02432-6 · Cited by 8
“Moreover, exosome/extracellular vesicles-based therapies are emerging as a promising approach for the treatment and management of AD (Sun and Chen 2024; Faraji et al. 2024; Jain et al. 2025).”
Graur, A., Erickson, N., Sinclair, P., Nusir, A., & Kabbani, N. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04357-3 · Cited by 7
“Our proteomic findings indicate that gp120C increases the expression of proteins Rising national rates in the use of nicotine products amongst young adults is driven by expansion in the use”
Extracellular Vesicles: A Promising Therapeutic Approach to Alzheimer's Disease
Mehrabadi, S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050365314250112042136 · Cited by 3
Silva, R., Monteiro, J., Ramalho, M. J., Andrade, S., Loureiro, J. A., & Pereira, M. C. (2026) · Pharmaceuticals · doi:10.3390/ph19050685 · Cited by 2
“…(i) to establish communication between cells and tissues by exchange of their intrinsic content; (ii) as diagnostic biomarkers; (iii) as DDS due to their properties (high stability, minimal immunogenicity, ease in crossing biological barriers, target specific cells or tissues, etc.) [111,112].”
Parameshwar, K., Das, I. J., Shaik, H. R., & Samal, H. B. (2025) · Next research. · doi:10.1016/j.nexres.2025.100910 · Cited by 3
Islam, A. W., Rao, Z. K., Wilkhoo, H. S., Singh, B., Hussain, S., & Kadam, S. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004137 · Cited by 2
Yadav, B., Gangwar, P., Kumari, K., Yadav, A., Rao, R., Kumar, K., Verma, H., Dhiman, M., & Mantha, A. K. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1835778 · Cited by 3
“Studies have shown that exosomes from AD brains carry oligomeric A β and enter recipient 10.3389/fnsyn.2026.1835778 neurons through dynamin-dependent endocytosis, delivering A β directly into the endosomal-lysosomal system (Sun and Chen, 2024).”
InfluentialŚwiątek, A., Kusiak, A., & Maj, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135888 · Cited by 2
“Lipids are involved not only in the processing of amyloid precursor protein but also in synaptogenesis, myelin formation, inflammation, oxidative stress, and other mechanisms contributing to the progression of Alzheimer’s disease pathology [41–43].”
InfluentialUnveiling the intricacies of exosome biology: from biogenesis to therapeutic applications
Mendonca, A., Acharjee, A., Sansare, Y., & Sundaresan, S. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-025-02418-w · Cited by 3
“The involvement of exosomes in intercellular communication and disease progression in Alzheimer’s disease has begun to unfold (Sun and Chen 2024).”
Mushtaq, T., Hameed, H., Paiva‐Santos, A. C., Tariq, U., & Hameed, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05189-6 · Cited by 2
“More recently, the study of extracellular vehicles (EVs), especially exosomes, has highlighted their importance in the pathogenic processes of AD, offering new avenues for potential therapeutic strategies [9].”
Andreadou, E. G., Evangelopoulou, E., Tsolaki, M., Tsamesidis, I., Pessach, I., & Mitka, S. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48080808 · Cited by 2
“As a cell-free alternative to stem cell transplantation, MSC-Exos retain several beneficial properties of their parent cells while avoiding some limitations associated with direct cell therapy, such as oncogenesis and immune rejection [17,43,44].”
Hong, Z., Zhang, S., Zhang, S., Zhao, Y., Ye, X., Shu, X., Chen, Y., Yan, S., & Ma, R. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1444873 · Cited by 2
Exosomes: A promising drug delivery tool in hepatic drug delivery
Kanojia, N., Thapa, K., Singh, T. G., & Verma, N. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106761 · Cited by 7
Fan, X., Ye, X., Xu, J., Mao, T., Zhang, R., Zhou, X., Yeung, C. C. K. A., Li, C., Chang, R. C., Lin, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202509376 · Cited by 3
Extracellular Vesicles in Hematological Malignancies
Zuberi, S., & Khalife, J. (2025) · Physiology · doi:10.5772/intechopen.1009285
Scouting Biomarkers for Alzheimer’s Disease via Network Analysis of Exosome Proteomics Data
Sagonas, A., Apostolakou, A. E., Litou, Z. I., Antonelou, M. H., & Iconomidou, V. A. (2025) · BioMedInformatics · doi:10.3390/biomedinformatics5020019
“Several studies have identified interactions between alpha-synuclein and tau, which may have implications for various neurodegenerative diseases [72–74].”
Zhanina, M. Y., Druzhkova, T. A., Vladimirova, E. E., Guekht, A. B., & Gulyaeva, N. V. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700539
Aβ Modulates Extracellular Vesicles Proteomic Profile Impacting Phosphorylation Mediators
Vaz, M., Martins, T. S., Trigo, D., Silva, O. A. B. D. C. E., Amado, F. M. L., Vitorino, R. M. P., & Henriques, A. G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05343-0 · Cited by 1
“Indeed, EVs were reported to contribute to Aβ and tau spreading, inflammation, and oxidative stress, in contrast to a positive effect as contributors to Aβ degradation, microglia-mediated Aβ clearance, or even Aβ oligomers sequestration [88, 89].”
Insulin signaling in confluent diabetes and AD
Abraham, A., Gangadhara, V., & Baliga, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40559-4.00008-8
Crossing the blood–brain barrier: exosomes in neurological research
Prakāsh, C., Saran, S., & Sharma, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36390-0.00019-1
Hoveizi, E., Karimi, A., Khajehpour, L., Ghotbeddin, Z., & Pyecroft, S. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116196
Extracellular Vesicles in Neurodegenerative Diseases: Tools for Therapy and Regeneration
Bakr, M., Gobba, F., Sabry, M., & Salama, M. (2026) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-032-12705-1_3
Gene Therapy and RNA-Based Innovations for Management of Alziemer's
Tiwari, J., Anand, P., Kumar, D., & Singh, S. N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010011
Exosomes in Amyloid Propagation—Roles in Neurodegeneration
Mishra, R., & Upadhyay, A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05913-w
“In diseases like AD and PD, exosomes from neurons and glial cells can carry protein aggregates to the neighboring cells and are followed by their internalization [206, 207].”
Adipose Tissue–Brain Crosstalk: The Role of Adipokines in the Regulation of Cognitive Function
Żołyniak, M., Soczyńska, J., Kania, K., Szwach, J., Kurowski, M., Gawełczyk, W., & Woźniak, S. (2026) · Obesities · doi:10.3390/obesities6030032
“Evidence also suggests that EVs may contribute to the pathogenesis of AD, as they can transport amyloid precursor protein (APP) as well as enzymes involved in its processing [51–53].”
Alavi, S. E., Shahmabadi, H. E., Love, R. M., Vasudevan, A. K., Sharma, L. A., & Sharma, A. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00802-5
“MVBs are considered the progenitors of exosomes (Sun and Chen 2024).”
InfluentialAnwer, T., Verma, A., Asiri, A., Alaklobie, M., Albaqami, A., ALSHAHRANI, F., Aly, K., Sharma, M., Siddiqui, S., Alam, N., et al. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02587-w · Cited by 1
“Consequently, disease-asso - ciated exosomes integrate multiple pathological pathways into a common molecular signature that reflects the com - plexity of AD progression (Sun & Chen 2024).”
Biochemical stress markers in neurodegeneration: Insights from 3D cellular models
Genovese, I., Laurenti, D., Risola, D. D., Mattioli, R., & Mosca, L. (2026) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2026.103360 · Cited by 1
Exosomal innovations in neurodegenerative disorders: Emerging insights and intranasal route
Hirlekar, R. S., Agnihotri, S., Sathe, S., & Nagarsenkar, M. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154474
Exosome-amyloid interplay: Mechanisms, pathological roles, and materials-driven opportunities
Nazari, M., & Rabiee, N. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116274
Metadata
- Authors
- Sun, M., & Chen, Z.
- Affiliations
- Changzhou No.2 People's Hospital (CN)
- Corresponding author
- Sun, Mingyue
- Chen, Zhuoyou
- Venue
- Journal of Inflammation Research
- Publisher
- Informa UK Limited
- Published
- 2024-06
- Volume
- Volume 17
- Pages
- 3921-3948
- ISSN
- 1178-7031 (ISSN-L)
- PMC
- PMC11193473
- OpenAlex
- W4399787176
- Cited by
- 39
- References
- 249
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Inflammation Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- exosomes, Alzheimer's disease, extracellular vesicles, amyloid-beta, tau hyperphosphorylation, neurofibrillary tangles, exosome biogenesis, intercellular communication, neurodegeneration, early detection, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.